Crysvita (burosumab) - Risk of severe hypercalcaemia
09/10/2025
Medicines for human use
Direct healthcare professional communication (DHPC)
Important Safety Information from Kyowa Kirin International regarding Crysvita (burosumab): Risk of severe hypercalcaemia